摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

methyl (S)-2-azido-3-(1H-indol-3-yl)propanoate | 1192373-21-9

中文名称
——
中文别名
——
英文名称
methyl (S)-2-azido-3-(1H-indol-3-yl)propanoate
英文别名
methyl (2S)-2-azido-3-(1H-indol-3-yl)propanoate
methyl (S)-2-azido-3-(1H-indol-3-yl)propanoate化学式
CAS
1192373-21-9
化学式
C12H12N4O2
mdl
——
分子量
244.253
InChiKey
ORHPNXHEOBIPSK-NSHDSACASA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    18
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    56.4
  • 氢给体数:
    1
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    methyl (S)-2-azido-3-(1H-indol-3-yl)propanoate四丁基氟化铵copper(II) sulfate 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 16.17h, 生成 C2HF3O2*C32H33N9O7
    参考文献:
    名称:
    Universal Peptidomimetics
    摘要:
    This paper concerns peptidomimetic scaffolds that can present side chains in conformations resembling those of amino acids in secondary structures without incurring excessive entropic or enthalpic penalties. Compounds of this type are referred to here as minimalist mimics. The core hypothesis of this paper is that small sets of such scaffolds can be designed to analogue local pairs of amino acids (including noncontiguous ones) in any secondary structure; i.e., they are universal peptidomimetics. To illustrate this concept, we designed a set of four peptidomimetic scaffolds. Libraries based on them were made bearing side chains corresponding to many of the protein-derived amino acids. Modeling experiments were performed to give an indication of kinetic and thermodynamic accessibilities of conformations that can mimic secondary structures. Together, peptidomimetics based on these four scaffolds can adopt conformations that resemble almost any combination of local amino acid side chains in any secondary structure. Universal peptidomimetics of this kind are likely to be most useful in the design of libraries for high-throughput screening against diverse targets. Consequently, data arising from submission of these molecules to the NIH Molecular Libraries Small Molecule Repository (MLSMR) are outlined.
    DOI:
    10.1021/ja1071916
  • 作为产物:
    描述:
    L-色氨酸甲酯盐酸盐copper(ll) sulfate pentahydrate 、 1-(azidosulfonyl)-1H-imidazol-3-ium tetrafluoroborate 、 potassium hydrogencarbonate 作用下, 以 乙腈 为溶剂, 以84 %的产率得到methyl (S)-2-azido-3-(1H-indol-3-yl)propanoate
    参考文献:
    名称:
    从伯胺安全生产有机叠氮化物的自动化合成
    摘要:
    本文描述的是利用含有所有所需试剂(包括咪唑-1-磺酰叠氮化物四氟硼酸盐)的预包装胶囊开发一种自动化且可重复的方法,用于将伯胺转化为有机叠氮化物。除了手动将伯胺加载到反应容器中之外,整个反应和产物分离过程可以自动完成,无需用户进一步参与,并以高纯度提供所需的有机叠氮化物。这种实用且简单的基于胶囊的自动化方法提供了一种方便且安全的生成有机叠氮化物的方法,而无需处理或暴露潜在爆炸性试剂。
    DOI:
    10.1021/acs.joc.4c00603
点击查看最新优质反应信息

文献信息

  • Synthesis, Absorption, and Fluorescence Studies of Coumaryl-Labelled Amino Acids and Dipeptides Linked Via Triazole Ring
    作者:Santosh Kumari、Sunita Joshi、S. M. Abdul Shakoor、Devesh S. Agarwal、Siva S. Panda、Debi D. Pant、Rajeev Sakhuja
    DOI:10.1071/ch14708
    日期:——

    Fluorophores based on 4-triazolyl, 7-hydroxy-4-triazolylmethyl, 4-O-triazolylmethyl, and 7-O-triazolylmethyl coumaryl-tagged amino acids and dipeptides were synthesized by copper-catalyzed [3 + 2] cycloaddition reaction between azido- or alkynyl-functionalized coumarins with alkynyl- or azido-functionalized amino acid and dipeptides in good-to-excellent yields. Steady-state absorption and the fluorescence properties of the synthesized conjugates were studied. The chemical applicability of these amino acid and peptide-based fluorophores was successfully demonstrated by their linear elongation by further tagging them with appropriate C- or N-terminus amino acid.

    通过催化叠氮或炔基化香豆素与炔基或叠氮官能化氨基酸和二肽之间的[3 + 2]环加成反应,合成了基于 4-三唑基、7-羟基-4-三唑基甲基、4-O-三唑基甲基和 7-O-三唑基甲基香豆素标记的氨基酸和二肽的荧光团,产率从良好到极佳。研究了合成共轭物的稳态吸收和荧光特性。通过进一步标记适当的 C 端或 N 端氨基酸,这些基于氨基酸和肽的荧光团的线性延伸成功地证明了它们的化学适用性。
  • Design, Synthesis, and Activity Evaluation of Stereoconfigured Tartarate Derivatives as Potential Anti-inflammatory Agents <i>In Vitro</i> and <i>In Vivo</i>
    作者:Priya Kumari、Palwinder Singh、Jashanpreet Kaur、Rajbir Bhatti
    DOI:10.1021/acs.jmedchem.1c00880
    日期:2021.7.8
    enzymes suffer from nonoptimal selectivity, in particular for COX-2, we present here the results of purposely designed tartarate derivatives that exhibit favorable selectivity and significant effectiveness against COX-2 and LOX. Integrated approaches of molecular simulation, organic synthesis, and biochemical/physical experiments identified 15 inhibiting COX-2 and LOX with respective IC50 4 and 7 nM
    临床前和临床数据表明,炎症与许多疾病的发病机制密切相关,包括癌症、阿尔茨海默病和糖尿病。炎症级联反应涉及多种细胞因子,最终以 COX-2/LOX 的激活结束,以产生前列腺素白三烯。虽然这些酶的可用抑制剂具有非最佳选择性,特别是对 COX-2,但我们在此展示了特意设计的酒石酸盐衍生物的结果,这些衍生物对 COX-2 和 LOX 表现出良好的选择性和显着的有效性。分子模拟、有机合成和生化/物理实验的综合方法确定了15 个抑制 COX-2 和 LOX 的化合物,其 IC 504 和 7 纳米。在瑞士白化小鼠5 mg kg –1的剂量下,15在 2-3 小时内逆转了 65% 的痛觉和 33% 的炎症。我们发现实验和模拟之间有很好的一致性,并使用模拟来合理化我们的观察。
  • Development of a Potent and Selective HDAC8 Inhibitor
    作者:Oscar J. Ingham、Ronald M. Paranal、William B. Smith、Randolph A. Escobar、Han Yueh、Tracy Snyder、John A. Porco、James E. Bradner、Aaron B. Beeler
    DOI:10.1021/acsmedchemlett.6b00239
    日期:2016.10.13
    A novel, isoform-selective inhibitor of histone deacetylase 8 (HDAC8) has been discovered by the repurposing of a diverse compound collection. Medicinal chemistry optimization led to the identification of a highly potent (0.8 nM) and selective inhibitor of HDAC8.
    通过改变多种化合物的用途,发现了一种新型的,组蛋白乙酰基酶8(HDAC8)的同工型选择性抑制剂。药物化学的优化导致鉴定出了一种高效(0.8 nM)的HDAC8选择性抑制剂
  • Modification of the lead molecule: Tryptophan and piperidine appended triazines reversing inflammation and hyeperalgesia in rats
    作者:Priya Kumari、Sukhmeet Kaur、Jashanpreet Kaur、Rajbir Bhatti、Palwinder Singh
    DOI:10.1016/j.bmc.2019.115246
    日期:2020.1
    agent. Selective for COX-2 over COX-1, compound 10 exhibited IC50 0.02 µM for COX-2 and reversed acetic acid induced inflammation in rats by 73% when used at 10 mg kg-1 dose and the same dose of the compound also rescued the animals from inflammatory phase of formalin induced hyperalgesia. As evidenced by the results of molecular modeling studies supported by the nuclear Overhauser enhancement data,
    分子的结构优化使其适合于COX-2的活性位点口袋,占据了与天然底物花生四烯酸覆盖的空间相同的空间,有助于化合物10作为有效的消炎剂的出现。相对于COX-1,CO10-2具有选择性,对COX-2的IC50为0.02 µM,当以10 mg kg-1的剂量使用时,逆转乙酸引起的大鼠炎症反应的发生率为73%,相同剂量的化合物也可以挽救动物从福尔马林的炎症期诱发痛觉过敏。正如核Overhauser增强数据所支持的分子模型研究结果所证明的那样,COX-2活性位点口袋中分子的适当几何结构有助于其与Ser530的键/疏相互作用,
  • [EN] ERAP INHIBITORS<br/>[FR] INHIBITEURS D'ERAP
    申请人:UNIV LILLE
    公开号:WO2022129589A1
    公开(公告)日:2022-06-23
    The present disclosure relates to novel compounds of formula (I) which are useful as inhibitors of endoplasmic reticulum aminopeptidases (ERAP), in particular as inhibitors of ERAP2. The disclosure also relates to the therapeutic use of these compounds, in particular the use of these compounds in the treatment or prophylaxis of proliferative disorders, autoinflammatory disorders and autoimmune disorders.
    本公开涉及一种新型化合物,其化学式为(I),可用作内质网肽酶(ERAP)的抑制剂,特别是ERAP2的抑制剂。本公开还涉及这些化合物的治疗用途,特别是这些化合物在治疗或预防增生性疾病、自身免疫性疾病和自身免疫性疾病方面的应用。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸